Qian Dong

972 citations
54 papers · 512 indexed · h-index 13
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers)Hepatocellular Carcinoma Treatment and Prognosis (8 papers)Neuroblastoma Research and Treatments (8 papers)
Partner nations
ChinaUnited StatesIndia

In The Last Decade

Qian Dong

47 papers receiving 507 citations

Peers

Qian Dong
Comparison fields: 5 of 105
  • Surgery 154
  • Molecular Biology 121
  • Oncology 114
  • Pulmonary and Respiratory Medicine 91
  • Biomedical Engineering 72
Replace Xiaoying Liu with:
Xiaoying Liu United States
Joshua A. Hanson United States
Maria Luisa Barretta Italy
Kyung Jin Seo South Korea
Weifeng Liu China
Yuting He China
Du He China
Wenwen Zhang China
Yifeng Zhang China
Muhammad Shahbaz China
Qian Dong relative to Xiaoying Liu United States Xiaoying Liu's profile →
Citations per field
00.5×2.7×
Xiaoying Liu · 1×
Citations per year

Countries citing papers authored by Qian Dong

Since Specialization
Citations

This map shows the geographic impact of Qian Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Dong more than expected).

Fields of papers citing papers by Qian Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qian Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Dong. The network helps show where Qian Dong may publish in the future.

Co-authorship network of co-authors of Qian Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Qian Dong. A scholar is included among the top collaborators of Qian Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qian Dong. Qian Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 0
6 1
7 0
8 0
9 1
10 8
11 1
12 9
13 38
14
CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo.
16
15 9
16 1
17 12
18 8
19 0
20 8

About Qian Dong

Qian Dong is a scholar working on Hepatology, Cancer Research and Neurology, having authored 54 papers that have together received 512 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Neuroblastoma Research and Treatments (8 papers). The work is most often cited by research in Health Informatics (14 citations), Hepatology (44 citations) and Cancer Research (65 citations). Qian Dong has collaborated with scholars based in China, United States and India. Frequent co-authors include Yang Liu, Rongxing Yi, Xiwei Hao, Hongting Lu, Haitao Niu, Zhiqiang Li, Bin Wei, Ge Guan, Xuecheng Yang and Bin Li. Their work appears in journals such as Scientific Reports, Medicine and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026